Botswana Blood Products Import Market -- HS Code 3002 Trade Data & Price Trend (Q1 2025)

Botswana Blood Products Import (HS 3002) Key Takeaways

Botswana’s Blood Products import under HS Code 3002 surged in Q1 2025, with March spiking to $3.86M as unit prices jumped to $128.73/kg, signaling a shift toward premium products. The market is dominated by high-value human vaccines (like 30024190 at $197.58/unit) and bulk veterinary supplies, with suppliers like Abbott and Pfizer holding pricing power but creating concentration risks. South Africa supplies over half the volume but at lower value, while Belgium delivers high-value finished products, exposing geographic dependencies. This analysis, covering Q1 2025, is based on cleanly processed customs data from the yTrade database.

Botswana Blood Products Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood products, vaccines, toxins, and cultures. These products are critical for healthcare, pharmaceuticals, and research industries, driving consistent global demand due to their essential role in medical treatments and disease prevention. Botswana's Blood Products Import under this code reflects its reliance on these materials for public health and veterinary applications.

Current Context and Strategic Position

Botswana's Customs and Excise Department recently updated its tariff documents, including HS Code 3002, as part of the July 2025 Tariff Volume revisions [BURS]. This underscores the need for market vigilance, as regulatory changes can impact import costs and supply chains. Botswana's strategic position as an importer of these products highlights its dependence on global suppliers to meet domestic healthcare and agricultural needs. Monitoring hs code 3002 trade data is essential to anticipate disruptions and ensure stable access to these vital goods.

Botswana Blood Products Import (HS 3002) Price Trend

Key Observations

Botswana's blood products imports surged in March 2025, driving the Q1 total value to approximately 5.6 million USD, with unit prices fluctuating widely from $42.80/kg to $128.73/kg. This represents a strong quarter-over-quarter performance, heavily influenced by the March spike.

Price and Volume Dynamics

The Botswana Blood Products Import trend began Q1 with a slight value increase to 883.20K USD in February from 855.84K USD in January, accompanied by a drop in unit price to $42.80/kg, suggesting higher volume imports at lower costs. March then saw a dramatic rise, with value jumping to 3.86 million USD and unit price soaring to $128.73/kg, indicating a shift towards premium products or urgent demand. This volatility aligns with the updated customs tariffs and procedures introduced in early 2025, as detailed in the [BURS] downloads, which may have prompted accelerated or strategic imports. For the hs code 3002 value trend, such movements are typical in healthcare sectors, often driven by inventory replenishment cycles or response to regional health needs, with March likely reflecting post-seasonal stock builds.

Botswana Blood Products Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

According to yTrade data, Botswana's import market for HS Code 3002 in Q1 2025 is dominated by high-unit-price vaccines for human medicine, specifically under sub-code 30024190, which accounts for over half of the total import value at 2.89 million USD. This product, with a unit price of 197.58 USD per unit, indicates a focus on specialized, high-value medical goods rather than bulk commodities. No extreme price anomalies were identified in the data set for isolation.

Value-Chain Structure and Grade Analysis

The remaining imports under HS Code 3002 can be grouped into two main categories: bulk veterinary vaccines with lower unit prices around 17.19 USD per unit, making up the majority of shipment volume, and finished immunological products for retail use with higher unit prices up to 280.85 USD per unit. This structure shows a mix of fungible bulk items and differentiated manufactured goods, suggesting that Botswana's HS Code 3002 trade data reflects both mass-market and specialized healthcare needs.

Strategic Implication and Pricing Power

Suppliers of high-value human medicine products like vaccines hold significant pricing power due to their specialized nature, while veterinary product importers may face more competitive pricing. For businesses involved in Botswana HS Code 3002 import, strategic focus should prioritize securing reliable sources for high-margin human health products and managing cost efficiencies for bulk veterinary items.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Blood Products Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

SOUTH AFRICA is the dominant origin for Botswana's Blood Products imports in Q1 2025, with a 51.42% frequency share and 68.22% quantity share, but only a 24.35% value share. This gap between high quantity and lower value per unit suggests imports are focused on bulk or lower-end variants, such as raw blood materials or components, rather than finished products. BELGIUM shows a reverse pattern with a 50.62% value share but low quantity, indicating higher-value, possibly premium Blood Products shipments.

Origin Countries Clusters and Underlying Causes

The top origins form three clusters based on Botswana's Blood Products import data. The Volume/Hub Cluster includes SOUTH AFRICA, NETHERLANDS, and FRANCE, where high quantity shares point to roles as bulk suppliers for raw materials. The High-Yield Cluster features BELGIUM, IRELAND, and SWITZERLAND, with high value per unit implying specialized or finished Blood Products like plasma derivatives. The Transactional Cluster, led by SOUTH AFRICA and including UNITED STATES and GERMANY, has high frequency shares, likely due to regular medical supply chains needing fresh or just-in-time deliveries.

Forward Strategy and Supply Chain Implications

Botswana's heavy reliance on SOUTH AFRICA for bulk Blood Products imports creates supply chain risks, such as dependency on a single source for critical medical inputs. Diversifying sourcing to include more High-Yield partners like BELGIUM could stabilize access to premium products. Monitoring trade data for HS Code 3002 will help assess shifts in import patterns and ensure resilient supply chains for Blood Products.

Table: Botswana Blood Products (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Blood Products (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

In Q1 2025, the Botswana Blood Products import market shows a strong focus on high-value suppliers. According to yTrade data, suppliers with high value but low shipment frequency dominate, accounting for 57.39% of the total import value. The typical trade involves frequent transactions from high-value, high-frequency suppliers, who represent 41.16% of value and 81.62% of shipment activity for Botswana's Blood Products import suppliers.

Strategic Supplier Clusters and Trade Role

The remaining supplier groups have minimal impact, with low-value clusters contributing less than 2% of import value. The dominant high-value, low-frequency suppliers, such as Abbott Laboratories and Pfizer, indicate a Direct-to-Factory commercial persona, suggesting direct deals with manufacturers for specialized Blood Products under HS code 3002. This structure points to a market where bulk, high-value orders are common, while smaller, frequent shipments support routine needs.

Sourcing Strategy and Vulnerability

Botswana's import strategy should prioritize managing risks from reliance on few high-value suppliers, while leveraging high-frequency ones for supply stability. The recent customs tariff updates from [BURS] highlight potential cost increases, urging importers to monitor compliance and diversify sources to mitigate vulnerabilities in the Blood Products supply chain.

Table: Botswana Blood Products (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Blood Products Supplier lists

Action Plan for Blood Products Market Operation and Expansion

• Use hs code 3002 trade data to identify and diversify sourcing into high-value origins like Belgium, reducing over-reliance on South Africa for bulk supply and strengthening the Blood Products supply chain against disruptions.
• Prioritize sourcing high-margin human vaccines (e.g., sub-code 30024190) by analyzing unit price trends, as these products drive profitability in Botswana's Blood Products Import market and offset lower-margin veterinary items.
• Monitor and segment supplier clusters—focusing on high-value, low-frequency partners like OEMs—to negotiate direct contracts, ensuring stable access to specialized products and minimizing supply vulnerabilities for hs code 3002 trade.
• Track regulatory updates from BURS and align import schedules with high-frequency supplier shipments to manage tariff impacts and maintain cost efficiency within the Blood Products supply chain.
• Leverage shipment frequency data to optimize inventory levels, avoiding overstock of bulk veterinary products while ensuring availability of high-value human medicines, crucial for balancing Botswana Blood Products Import costs and demand.

Take Action Now —— Explore Botswana Blood Products Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Blood Products Import 2025 Q1?

A1. The March 2025 surge to 3.86 million USD, with unit prices peaking at $128.73/kg, reflects a shift toward premium products or urgent demand, likely influenced by updated customs tariffs and seasonal stock replenishment cycles.

Q2. Who are the main origin countries of Botswana Blood Products (HS Code 3002) 2025 Q1?

A2. SOUTH AFRICA dominates with a 68.22% quantity share, while BELGIUM leads in value (50.62%), indicating bulk vs. high-value product specialization.

Q3. Why does the unit price differ across origin countries of Botswana Blood Products Import?

A3. Price gaps stem from product specialization: bulk veterinary vaccines (17.19 USD/unit) vs. high-end human vaccines (up to 280.85 USD/unit) under sub-code 30024190.

Q4. What should importers in Botswana focus on when buying Blood Products?

A4. Prioritize securing high-margin human health products (e.g., vaccines) from high-value suppliers like Abbott Laboratories, while diversifying bulk veterinary sources to mitigate supply risks.

Q5. What does this Botswana Blood Products import pattern mean for overseas suppliers?

A5. Suppliers of premium products (e.g., Belgium, Switzerland) hold pricing power, while bulk exporters (e.g., South Africa) face competition but benefit from consistent demand.

Q6. How is Blood Products typically used in this trade flow?

A6. Imports serve both specialized human healthcare (high-value vaccines) and mass-market veterinary needs (bulk immunological products).

Detailed Monthly Report

Botswana HS3002 Import Snapshot 2025 JAN

Botswana HS3002 Import Snapshot 2025 FEB

Botswana HS3002 Import Snapshot 2025 MAR